Severity
Critical
FDA Drug recall · Reported December 25, 2013
Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine, N-Desmethylsibutramine and phenolphthalein. Sibutramine and phenolphthalein were previous…
Bethel Nutritional Consulting, Inc recalled Quick Thin (citrus aurantium extract, sweet potato fiber, cyamopsis gum powder, alfalfa, … - a critical-severity action.
Quick Thin (citrus aurantium extract, sweet potato fiber, cyamopsis gum powder, alfalfa, … was recalled by Bethel Nutritional Consulting, Inc in December 25, 2013. Reason: Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine, N-Desmethylsibutram…. Check the official notice for the remedy. Verify recall #D-371-2014 with the FDA Drug before acting.
The recall
Bethel Nutritional Consulting, Inc issued this critical-severity FDA Drug recall-Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine, N-Desmethylsibutram….
Sourced from official FDA Drug enforcement records. Verify recall #D-371-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-371-2014) was formally reported on December 25, 2013, with the manufacturer initiating the action on August 5, 2013. It is classified under Critical severity (Class I), with a current status of Terminated. Bethel Nutritional Consulting, Inc is listed as the recalling firm, operating out of New York, NY. Federal records list the affected scope as 9,121 bottles.
The documented reason for this recall is: Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine, N-Desmethylsibutramine and phenolphthalein. Sibutramine and phenolphthalein were previously available drug products but were remo… Distribution data in the federal record shows the product reached: Nationwide, Puerto Rico, and internet sales. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
9,121 bottles
Related Recalls
6
5 from same agency
Quick Thin (citrus aurantium extract, sweet potato fiber, cyamopsis gum powder, alfalfa, mulberry leaf, guarana, spirulina) capsules, 400 mg, 30-count bottle, Distributed by: Bethel, Inc., Tel: (212) 568-5330.
Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine, N-Desmethylsibutramine and phenolphthalein. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-371-2014 |
| Date reported | December 25, 2013 |
| Date initiated | August 5, 2013 |
| Recalling firm | Bethel Nutritional Consulting, Inc |
| Firm location | New York, NY |
| Affected scope | 9,121 bottles |
| Distribution | Nationwide, Puerto Rico, and internet sales |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported December 25, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.